Currently funded projects

Overview of research focus. The direct and indirect crosstalk between HDL and chemokines/chemokine-receptors

Targeting immune-lipid crosstalk in cardio-metabolic diseases: focus on HDL dependent regulation of chemokine-receptor signaling

Institution: Institute for Molecular Cardiovascular Research (IMCAR)
University clinic RWTH Aachen
Applicant: Emiel van der Vorst
EKFS funding line: first application

MR- and optoacoustic based Immunometabolic Profiling of Rheumatoid Arthritis MIRADOR

MR- and optoacoustic based Immunometabolic Profiling of Rheumatoid Arthritis

Institution: Medizinische Klinik 3 - Rheumatologie und Immunologie
Applicant: Dr. med. David Simon
EKFS funding line: Else Kröner-Memorial-Stipendium

In vivo high field MRI (left) and ultramicroscopy images (right) of the cleared brain shows the extent of tumor cell infiltration of S24 glioma cells (red). The microvasculature is stained with lectin-FITC (green).

Imaging of immune responses and tumor cell invasion in glioma models

Institution: Universitätsklinik Heidelberg – Deutsches Krebsforschungszentrum
Applicant: Dr. med. Michael Breckwoldt, Ph.D.
EKFS funding line: first application

Das Bild zeigt beteiligte Wissenschaftler und Arbeitsgruppenleiter auf dem Auftaktsymposium 2019 in Mainz.

The role of the diseased hepatic microenvironment for tumor initiation and progression in liver cancer

Institution: Universitätsmedizin Mainz
Applicants: Jens Marquardt, Beate Straub, Hauke Lang
EKFS funding line: Else Kröner-Forschungskolleg

Premalignant B cell receptor repertoire in 5 patients with a lymphoproliferative inborn error of immunity

Molecular biological analysis of inborn errors of immunity with intrinsic tumor predisposition

Institution: Department for Paediatric Immunology and Rheumatology, Dr von Hauner Children’s Hospital, Ludwig-Maximilians-University Munich
Applicant: PD Dr. med. Dr. sci. nat. Fabian Hauck
EKFS funding line: key project

histology of a murine psoriasis

Identification of novel inhibitors for the treatment of psoriasis

Institution: University of Tübingen, IFIB, Dept. of molecular medicine
Applicant: Daniela Kramer
EKFS funding line: first application

Project core team discussing data.

T cell lipid metabolism as an immune “checkpoint” in renal cell carcinoma.

Institution: University Hospital Regensburg
Applicant: Dr. Peter J. Siska
EKFS funding line: first application

Transcranial magnetic stimulation (TMS) laboratory

Defining clinical and neurophysiological markers of effective deep brain stimulation treatment in dystonia

Institution: Institute of Neurogenetics
Applicant: Dr. Anne Weißbach
EKFS funding line: first application

The second leading cause of death worldwide is stroke. Acute therapy is performed up to 8 hours after the event by restoring blood flow through thrombolysis or thrombectomy.

Secondary Brain Damage by T Lymphocytes after Experimental Stroke

Insitution: University Medicine Greifswald
Applicant: Antje Vogelgesang
EKFS funding line: first application

Flow cytometric analysis of DNA repair proteins

Identification of biomarkers for cellular radio- and chemosensitivity on peripheral blood cells from patients with inborn DNA repair defects

Institution: Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm
Applicant: Kerstin Felgentreff
EKFS funding line: first application